CVS Health Corporation with ticker code (CVS) now have 23 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low ranges between $104.00 and $74.00 suggesting an average Analsyt target price of $89.87. Now with the previous closing price of $80.36 this would imply there is now a potential upside of 11.8%. The 50 day MA is $72.45 and the 200 day MA is $71.40. The total market capitalization for the company now stands at 102.80B. The stock price for the company is currently $79.89 USD
The potential market cap would be $114,970,083,588 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 12.23, revenue per share of $268.63 and a 3.64% return on assets.
CVS Health Corporation, together with its subsidiaries, is a diversified health solutions company. The Company’s segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. Its Health Care Benefits offer a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare supplement plans, and Medicaid health care management services. Its Health Services provides a full range of pharmacy benefit management solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, and diagnostic testing.
